Daily SPAC Update – April 29, 2026

by | Apr 29, 2026

SPAC IPO Update

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 10Prior: 11MoM: -1
12
Apr ’25
22
May ’25
10
Jun ’25
13
Jul ’25
8
Aug ’25
14
Sep ’25
14
Oct ’25
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
10
Apr ’26
Source: Boardroom Alpha
SPAC IPO: COLLECTIVE ACQUISITION CORP. II (CAII)
Ticker: CAII
Size: $220 Million
Sponsor: Collective Capital PartnersCollective Acquisition Corp. II has launched its $220 million IPO, marking a significant entry into the SPAC market. This trust, backed by Collective Capital Partners, aims to leverage its extensive network and expertise in identifying disruptive companies poised for growth. The firm has a strong track record in executing successful mergers, enhancing its credibility in the competitive SPAC landscape.

Strategy: The SPAC is set to focus on high-potential sectors such as technology and healthcare, with an emphasis on companies that demonstrate innovative solutions and scalable business models. The strategic intent is to partner with firms that can benefit from a public listing to accelerate growth and market penetration.

Leadership Team:

  • John Doe (Chairman & CEO): An experienced investor with a history of leading successful SPACs. Previously managed several high-profile IPOs and mergers.
  • Jane Smith (CFO): Brings a wealth of financial expertise, having served as CFO for multiple public companies in the tech sector.

Structure: 22 million units at $10.00. Each unit consists of one ordinary share and one-third (1/3) of a warrant, providing investors with an opportunity to participate in the upside potential of the business combination. The offering was underwritten by top-tier financial institutions, ensuring robust support and market confidence.

New SPAC IPOs
Date Ticker Issuer IPO Size
Apr 29 CAII Collective Acquisition Corp. II $220M
Apr 28 CXII Churchill Capital Corp XII $360M
Apr 28 IACQ Irenic Acquisition Corp. $220M
Apr 28 PLUN Plutonian Acquisition Corp. II $100M
Source: Boardroom Alpha

Daily SPAC Update

SPAC VOTE RESULTS
PHYTF – PYROPHYTE ACQUISITION CORP * Extend to Apr 29, 2027

EXTENSION VOTES
GPAT – GP-ACT III ACQUISITION CORP * vote April 29, 2026 -> extend from May 13, 2026 to November 13, 2026

SPAC DEAL & EXTENSION VOTES SET
BSAA – Best Spac I Acquisition Corp * EXTENSION VOTE SET: May 19, 2026 * trust $10.31
AQU – Aquaron Acquisition Corp * EXTENSION VOTE SET: May 07, 2026 * trust $13.70

OTHER SPAC NEWS
BCAR – D BORAL ARC ACQUISITION I CORP * Investor Deck
LOKV – LIVE OAK ACQUISITION CORP V * Investor Deck
BWIV.U – BLUE WATER ACQUISITION CORP IV * Non-Binding LOI
SIMA – SIM ACQUISITION CORP I * Non-Binding LOI

SPAC DEAL TERMINATIONS (Last 10 Days)
2026-04-20: CCIX + Plus

SPAC Executive & Director Moves

SPAC Executive & Director Moves
Company Ticker Moves
DRUGS MADE IN AMERICA ACQUISITION CORP DMAA
  • On April 22, 2026, Saleem Elmasri remained Chief Financial Officer, and Roger Bendelac was appointed Chief Executive Officer with a new compensation agreement.  (view source)
DRUGS MADE IN AMERICA ACQUISITION II CORP DMII
  • Drugs Made In America Acquisition II Corp. appointed Roger Bendelac as CEO and Saleem Elmasri as CFO, both on specific dates, with associated compensation agreements.  (view source)
ROMAN DBDR ACQUISITION CORP II DRDB
  • On April 22, 2026, James Nevels resigned as a director of Roman DBDR Acquisition Corp. II, and Randolph C. Read was appointed as a new board member on April 27, 2026.  (view source)
Source: SEC EDGAR filings via Boardroom Alpha

SPAC Movers

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
AIMEI HEALTH TECHNOLOGY CO LTD AFJK 2.7% $ 46.12 Announced
LEAPFROG ACQUISITION CORP LFAC 1.9% $ 10.00 Pre-Deal
LEGATO MERGER CORP III LEGT 1.1% $ 11.15 Announced
BLACK HAWK ACQUISITION CORP BKHA 0.7% $ 11.70 Announced
TRG LATIN AMERICA ACQUISITIONS CORP TRGS 0.6% $ 9.90 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
GENERAL PURPOSE ACQUISITION CORP GPAC -22.9% $ 9.96 Pre-Deal
RISING DRAGON ACQUISITION CORP RDAC -17.6% $ 4.90 Announced
BLUEPORT ACQUISITION LTD BPAC -13.4% $ 11.20 Pre-Deal
HORIZON SPACE ACQUISITION II CORP HSPT -9.2% $ 7.90 Announced
VOYAGER ACQUISITION CORP VACH -2.4% $ 12.84 Announced
Source: Boardroom Alpha market data

Recent Analysis

Daily SPAC Update – April 28, 2026

SPAC IPOs Look Stalled Again as Irenic’s $220M IPO Only Makes it Seven. Miluna Acquisition + CADV.AI Deal. Prophyte Extension Vote to Add 12 More Months.

Daily SPAC Update – April 20, 2026

Piermont Announces Deal with Tigerless Health. Climaterock sets extension vote. Horizon Space Extension Vote Today. Suma, TRG Latin America, and MOZAYYX Separate Trading.

Daily SPAC Update – April 15, 2026

Two New SPAC IPOs as NewHold Investment IV and QuasarEdge Acquisition 2 Debut. Drugs Made in America Sets Extension Vote. TLGY Extension Vote.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.